Colorectal and Lung Tumoroids are Now Available NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions NEW Blog Post - Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con

Colorectal and Lung Tumoroids are Now Available NEW Blog Post - Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter Discovery Partners with PathAI to Develop First AI-Powered Biospecimen Solutions NEW Blog Post - Leverage Permeabilized Hepatocytes for Difficult Drug Compounds in Metabolism Studies Discovery Announces Upcoming Launch of Tumoroids at Precision Med Tri-Con

NextGen Omics 2025

Boston, MA
March 27, 2025 – March 28, 2025

Venue:

Sheraton Boston Hotel

39 Dalton Street, Boston, Massachusetts, USA, 02199

Privacy Settings